Literature DB >> 2537011

Molecular diagnosis of genital human papillomavirus infection: comparison of two methods used to collect exfoliated cervical cells.

S H Vermund1, M H Schiffman, G L Goldberg, D B Ritter, A Weltman, R D Burk.   

Abstract

Human papillomavirus infection is implicated as an etiologic agent in the development of neoplasia and invasive carcinoma of the cervix. To detect human papillomavirus infection of the cervix, cells must be collected and assayed for human papillomavirus-related deoxyribonucleic acid sequences. Gynecologists and other clinical investigators generally use an exocervical spatula scrape and an endocervical swab for cell collection, analogous to Papanicolaou smear collection. However, inadequate cell recovery is common. To overcome this problem, we have developed the cervicovaginal lavage method for human papillomavirus detection. In the present study we compared the cervicovaginal lavage method with the widely used scrape-swab method in 48 women referred for colposcopic examination. After a Papanicolaou test, two samples were obtained from each woman, either with cervicovaginal lavage followed by scrape-swab or with the scrape-swab followed by cervicovaginal lavage. Human papillomavirus types were assessed by restriction analysis and Southern blot hybridization. In 21 women (44%) test results were positive for human papillomavirus with both the scrape-swab and cervicovaginal lavage cell collection methods; in nine women (19%) test results were positive only with the cervicovaginal lavage method; and in 18 women (38%) results were negative for human papillomavirus with both techniques. None of the women had human papillomavirus detected by scrape-swab without also having it detected with cervicovaginal lavage. The human papillomavirus deoxyribonucleic acid types identified were concordant in the 21 women whose infections were detected with both sampling methods, although the second virus type was detected only with cervicovaginal lavage in one woman who had a mixed genital tract infection. We concluded that cervicovaginal lavage is a more sensitive cell collection method than the scrape-swab technique for assessing human papillomavirus infection of the cervix.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537011     DOI: 10.1016/0002-9378(89)90430-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.

Authors:  J U Cope; A Hildesheim; M H Schiffman; M M Manos; A T Lörincz; R D Burk; A G Glass; C Greer; J Buckland; K Helgesen; D R Scott; M E Sherman; R J Kurman; K L Liaw
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA.

Authors:  M H Schiffman; H M Bauer; A T Lorincz; M M Manos; J C Byrne; A G Glass; D M Cadell; P M Howley
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.

Authors:  Akhila Balasubramanian; Shalini L Kulasingam; Atar Baer; James P Hughes; Evan R Myers; Constance Mao; Nancy B Kiviat; Laura A Koutsky
Journal:  J Low Genit Tract Dis       Date:  2010-07       Impact factor: 1.925

4.  Relative accuracy of nucleic acid amplification tests and culture in detecting Chlamydia in asymptomatic men.

Authors:  H Cheng; M Macaluso; S H Vermund; E W Hook
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.

Authors:  Marla J Keller; Robert D Burk; Xianhong Xie; Kathryn Anastos; L Stewart Massad; Howard Minkoff; Xiaonan Xue; Gypsyamber D'Souza; D Heather Watts; Alexandra M Levine; Philip E Castle; Christine Colie; Joel M Palefsky; Howard D Strickler
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

6.  Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format.

Authors:  J R Kornegay; A P Shepard; C Hankins; E Franco; N Lapointe; H Richardson; F Coutleé
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

7.  Use of AffiProbe HPV test kit for detection of human papillomavirus DNA in genital scrapes.

Authors:  M Ranki; A W Leinonen; T Jalava; P Nieminen; V R Soares; J Paavonen; A Kallio
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

8.  Human papillomavirus, gonorrhea, syphilis, and cervical dysplasia in jailed women.

Authors:  N A Bickell; S H Vermund; M Holmes; S Safyer; R D Burk
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

9.  Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay.

Authors:  F Coutlée; D Provencher; H Voyer
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

10.  Partner Human Papillomavirus Viral Load and Incident Human Papillomavirus Detection in Heterosexual Couples.

Authors:  Mary K Grabowski; Xiangrong Kong; Ronald H Gray; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Steven J Reynolds; Maria J Wawer; Andrew D Redd; Stephen Watya; Thomas C Quinn; Aaron A R Tobian
Journal:  J Infect Dis       Date:  2015-11-23       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.